Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

[Expression and roles of the epithelial mesenchymal transition markers E-cadherin and vimentin in hepatocellular carcinoma].

Li YM, Han KQ, Zheng L, Li J, Xu SC, Tian YW, Li HY, Pi HF, Qian P, Liang P.

Zhonghua Gan Zang Bing Za Zhi. 2013 Apr;21(4):279-84. doi: 10.3760/cma.j.issn.1007-3418.2013.04.010. Chinese.

PMID:
24021790
2.

Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.

Li YM, Xu SC, Li J, Han KQ, Pi HF, Zheng L, Zuo GH, Huang XB, Li HY, Zhao HZ, Yu ZP, Zhou Z, Liang P.

Cell Death Dis. 2013 Oct 3;4:e831. doi: 10.1038/cddis.2013.347.

3.

[Gli1 expression and its relationship with the expression of Shh, Vimentin and E-cadherin in human hepatocellular carcinoma].

Xu QR, Zheng X, Zan XF, Yao YM, Yang W, Liu QG.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 May;28(5):536-9. Chinese.

PMID:
22558994
4.

Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).

Bao YX, Cao Q, Yang Y, Mao R, Xiao L, Zhang H, Zhao HR, Wen H.

Diagn Pathol. 2013 Dec 6;8:197. doi: 10.1186/1746-1596-8-197.

5.

Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.

Zhai X, Zhu H, Wang W, Zhang S, Zhang Y, Mao G.

Med Oncol. 2014 Jun;31(6):970. doi: 10.1007/s12032-014-0970-z. Epub 2014 Apr 30.

PMID:
24781336
6.

[Expression of sal-like 4 in primary hepatocellular carcinoma and its association with epithelial-mesenchymal transition].

Xu J, Wang J, Hu Y, Wang XX, Cheng LL, Yu HY.

Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):500-505. doi: 10.3760/cma.j.issn.1007-3418.2016.07.004. Chinese.

PMID:
27784427
7.

The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.

Xiao S, Liu L, Lu X, Long J, Zhou X, Fang M.

J Cancer Res Clin Oncol. 2015 Aug;141(8):1465-74. doi: 10.1007/s00432-015-1937-y. Epub 2015 Feb 26.

PMID:
25716692
8.

BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.

Xiao S, Liu L, Fang M, Zhou X, Peng X, Long J, Lu X.

Dig Dis Sci. 2015 Apr;60(4):910-8. doi: 10.1007/s10620-014-3411-0. Epub 2014 Nov 2.

PMID:
25362514
9.

[Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].

He N, Wu GF, Zhao HY, Han HX.

Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):758-61. Chinese.

PMID:
22336160
10.

[Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].

Xu J, Wang J, Hu Y, Cheng L, Yu H.

Zhonghua Zhong Liu Za Zhi. 2015 Aug;37(8):585-90. Chinese.

PMID:
26714598
11.

Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma.

Fan M, Liu Y, Xia F, Wang Z, Huang Y, Li J, Wang Z, Li X.

Tumori. 2013 Nov-Dec;99(6):689-96. doi: 10.1700/1390.15457.

PMID:
24503792
12.

Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.

Zhao J, Dong D, Sun L, Zhang G, Sun L.

Int Braz J Urol. 2014 Mar-Apr;40(2):179-89. doi: doi: 10.1590/S1677-5538.IBJU.2014.02.07.

13.

[The role of hexokinase 2 in the metastasis of hepatocellular carcinoma cells].

Geng XL, Long WH, Hai J, Zhang Y, Zheng W, Zhang ZY, Du LX.

Zhonghua Zhong Liu Za Zhi. 2016 Oct 23;38(10):739-742. doi: 10.3760/cma.j.issn.0253-3766.2016.10.005. Chinese.

PMID:
27784456
14.

[Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].

Zhang Z, Bai Y, Li P, Zhao J, Wang Y, Sun L, Tang J.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Nov;27(22):1265-8. Chinese.

PMID:
24616987
15.

[Expression of Nodal in hepatocellular carcinoma and its relationship with angiogenesis and epithelial-mesenchymal transition].

Chen J, Li J, Liu W, Jia W, Xu G, Ma J.

Zhonghua Wai Ke Za Zhi. 2014 Mar;52(3):188-92. Chinese.

PMID:
24785457
16.

Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients.

He L, Zhou X, Qu C, Tang Y, Zhang Q, Hong J.

Med Oncol. 2013 Dec;30(4):707. doi: 10.1007/s12032-013-0707-4. Epub 2013 Aug 31.

PMID:
23996242
17.

HtrA1 regulates epithelial-mesenchymal transition in hepatocellular carcinoma.

Zhu F, Duan YF, Bao WY, Liu WS, Yang Y, Cai HH.

Biochem Biophys Res Commun. 2015 Nov 20;467(3):589-94. doi: 10.1016/j.bbrc.2015.09.105. Epub 2015 Sep 25.

PMID:
26403966
18.

Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.

Luo W, Fang W, Li S, Yao K.

Int J Cancer. 2012 Oct 15;131(8):1863-73. doi: 10.1002/ijc.27467. Epub 2012 Mar 15.

19.

The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma.

Huang J, Qiu Y, Chen G, Huang L, He J.

Med Oncol. 2012 Sep;29(3):1606-13. doi: 10.1007/s12032-011-9998-5. Epub 2011 Jun 8.

PMID:
21656027
20.

MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S.

Eur J Surg Oncol. 2014 Nov;40(11):1586-94. doi: 10.1016/j.ejso.2013.11.008. Epub 2013 Nov 19.

PMID:
24290372

Supplemental Content

Support Center